| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |